Venous Insufficiency. Saphenous Vein. Varicose Veins.
Conditions
Interventions
In this study, two surgical interventions were performed in the same patient, with a space of 40 days between the same.
Treatment of internal saphenous insufficiency with endolaser or radiofrequency w
Procedure/surgery
E07.632.490
E02.594
Sponsors
Universidade Federal do Rio de Janeiro
Universidade Federal do Rio de Janeiro
Eligibility
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients older than 18 years; with symptomatic venous disease of the lower limbs; with bilateral great saphenous vein reflux.
Exclusion criteria
Exclusion criteria: Patients without clinical conditions to be submitted to the proposed treatment; on the use of anticoagulants or with a diagnosis of coagulation disorder; carriers of chronic or acute inflammatory disease; history of neoplasia; age greater than 70 years; women who are pregnant or intending to become pregnant; women in lactation; presence of signs of peripheral obstructive arterial disease (ankle-arm index> 0.9); history of prior varicose vein surgery; presence of significant reflux in the external saphenous vein or perforating vein, by the DUS evaluation; presence of reflux in the deep venous system, signs of superficial thrombophlebitis and recent or old thrombosis in the deep venous system, by the DUS evaluation; with lymphedema.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1 Superiority of the 1470 nm endolaser in the control of the internal saphenous vein reflux and the internal saphenous collusion rate through the evaluation by color venous echo Doppler.;Result Found 1 Similar results were observed between the two methods in the control of internal saphenous vein reflux and in the internal saphenous collusion rate by color venous echocardiography.;Expected outcome 2 Superiority of endolaser 1470 nm in the control of symptoms related to the disease, through the evaluation of CEAP and RVCSC scores.;Result Found 2 Similar results were observed between the two methods in the control of symptoms related to the disease, through the evaluation of the CEAP and RVCSC scores.;Expected outcome 3: Superiority of endolaser 1470 nm in the assessment of postoperative morbidity through visual pain scale, incidence of complications and time of return to work.;Outcome found 3: Similar results were observed between the two methods in the assessment of postoperative morbidity, through visual pain scale, incidence of complications and time of return to work. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactMárcio Filippo
Universidade Federal do Rio de Janeiro
Outcome results
None listed